Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jun, Tsukimoto"'
Autor:
Yuto Horii, Toshiki Iniwa, Masayoshi Onitsuka, Jun Tsukimoto, Yuki Tanaka, Hironobu Ike, Yuri Fukushi, Haruna Ando, Yoshie Takeuchi, So-ichiro Nishioka, Daisuke Tsuji, Mariko Ikuo, Naoshi Yamazaki, Yoshiharu Takiguchi, Naozumi Ishimaru, Kohji Itoh
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 25, Iss , Pp 297-310 (2022)
Galactosialidosis (GS) is a lysosomal cathepsin A (CTSA) deficiency. It associates with a simultaneous decrease of neuraminidase 1 (NEU1) activity and sialylglycan storage. Central nervous system (CNS) symptoms reduce the quality of life of juvenile/
Externí odkaz:
https://doaj.org/article/c205affe2a714860b2af6ebf4b800e26
Autor:
Hiroki Tanaka, Daisuke Tsuji, Ryosuke Watanabe, Yukiya Ohnishi, Shindai Kitaguchi, Ryuto Nakae, Hiromi Teramoto, Jun Tsukimoto, Yuto Horii, Kohji Itoh
Publikováno v:
Journal of Inherited Metabolic Disease. 45:1191-1202
Lysosomal storage disorders (LSDs) are inherited metabolic diseases caused by genetic defects in lysosomal enzymes or related factors. LSDs are associated with excessive accumulation of natural substrates in lysosomes leading to central nervous syste
Autor:
Jun Tsukimoto, Yoshie Takeuchi, Yuto Horii, Toshiki Iniwa, Yuri Fukushi, So-ichiro Nishioka, Kohji Itoh
Publikováno v:
ACS Applied Bio Materials. 5:205-213
Autor:
Kotaro, Koiwai, Jun, Tsukimoto, Tetsuya, Higashi, Fumitaka, Mafuné, Ken, Miyajima, Takanori, Nakane, Naohiro, Matsugaki, Ryuichi, Kato, Serena, Sirigu, Arjen, Jakobi, Matthias, Wilmanns, Michihiro, Sugahara, Tomoyuki, Tanaka, Kensuke, Tono, Yasumasa, Joti, Makina, Yabashi, Osamu, Nureki, Eiichi, Mizohata, Toru, Nakatsu, Eriko, Nango, So, Iwata, Leonard M G, Chavas, Toshiya, Senda, Kohji, Itoh, Fumiaki, Yumoto
Publikováno v:
ACS applied bio materials. 2(11)
Autor:
Jun, Tsukimoto, Yoshie, Takeuchi, Yuto, Horii, Toshiki, Iniwa, Yuri, Fukushi, So-Ichiro, Nishioka, Kohji, Itoh
Publikováno v:
ACS applied bio materials. 5(1)
Human neuraminidase 1 (NEU1) is a lysosomal glycosidase that cleaves the terminal sialic acids of sialylglycoconjugates. NEU1 is biosynthesized in the endoplasmic reticulum (ER) lumen as an
Autor:
Akira Shigenaga, Chiaki Komiya, Jun Tsukimoto, Takuya Morisaki, Akira Otaka, Kohji Itoh, Masahiro Ueda, Tsubasa Inokuma
Publikováno v:
Chemical Communications. 55(49):7029-7032
A traceless thioester-producing protocol featuring carboxypeptidase Y-mediated hydrazinolysis of cysteinyl prolyl leucine-tagged peptides has been developed. The hydrazinolysis followed by thioesterification affords cysteinyl prolyl thioesters. Self-
Autor:
Miki Ueno, Eiji Nanba, Hideki Nakajima, Kaori Adachi, A. Kawakami, Aya Narita, Kohji Itoh, Jun Tsukimoto
Publikováno v:
Human Genome Variation, Vol 6, Iss 1, Pp 1-5 (2019)
Human Genome Variation
Human Genome Variation
Galactosialidosis is an autosomal recessive lysosomal storage disease caused by the combined deficiency of lysosomal β-galactosidase and neuraminidase due to a defect in the protective protein/cathepsin A. Patients present with various clinical mani
Autor:
Yuri Fukushi, Yuuto Horii, Daisuke Tsuji, Toshiki Iniwa, Haruna Ando, Kohji Itoh, Jun Tsukimoto
Publikováno v:
Molecular Genetics and Metabolism. 129:S78-S79
Autor:
Mustafizur Rahman, Seiji Hitaoka, Daisuke Tsuji, Takatsugu Hirokawa, Tatsusada Yoshida, Jun Tsukimoto, Kohji Itoh, Hiroshi Chuman
Publikováno v:
Biochemistry and Biophysics Reports
Human cytosolic sialidase (Neuraminidase 2, NEU2) catalyzes the removal of terminal sialic acid residues from glycoconjugates. The effect of siastatin B, known as a sialidase inhibitor, has not been evaluated toward human NEU2 yet. We studied the reg